Bliss GVS Pharma Limited NSE Symbol:BLISSGVS, BSE Security Code:506197 has declared its 3rd(third) quarter unaudited consolidated financial report from the month of October, 2020 to the month of December, 2020; for the fiscal year 2020-21.
| Revenue Reported by Bliss GVS Pharma Limited for Third Quarter FY, 2020-21 |
| Current Quarter (October, 2020 - December, 2020) |
Previous Quarter (July, 2020 - September, 2020) |
Corresponding Quarter (October, 2019 - December, 2019) |
9 Months Ended (April, 2020 - December, 2020) |
Corresponding 9 Months Ended (April, 2019 - December, 2019) |
| 168.18 |
154.28 |
153.37 |
459.05 |
590.03 |
| Calculated Revenue of Bliss GVS Pharma Limited for Third Quarter FY, 2020-21 |
| Current(December, 2020) VS Previous(September, 2020) |
Current(December, 2020) VS Corresponding(December, 2019) |
9 months Ended(April, 2020 - December, 2020) VS Corresponding 9 months Ended(April, 2019 - December, 2019) |
| Change |
Change % |
Change |
Change % |
Change |
Change % |
| 13.90 |
9.01%(Revenue Increase) |
14.81 |
9.66%(Revenue Increase) |
130.98 |
22.20%(Revenue Decrease) |
Revenue: Bliss GVS Pharma Limited's financial report shows that the company's revenue increased by 9.01% in QoQ(Quarter on Quarter) / current quarter(October, 2020 - December, 2020) for revenue increase of Rs.13.90 crores, as the company posted revenue of Rs.168.18 crores; in compare to previous quarter(July, 2020 - September, 2020) when the company reported revenue of Rs.154.28 crores.
The result also shows that the company's revenue increased by 9.66% in YoY(Year over Year) / in current quarter(October, 2020 - December, 2020) for revenue increase of Rs.14.81 crores; in compare to corresponding quarter(October, 2019 - December, 2019) when the company posted revenue of Rs.153.37 crores.
The company also reported that its revenue decreased by 22.20% in 9 months end(April, 2020 - December, 2020) for revenue decrease of Rs.130.98 crores, since the company reported revenue of Rs.459.05 crores; in compare to corresponding 9 months end(April, 2019 - December. 2019) when the company posted revenue of Rs.590.03 crores.
| Gross Margin(%) Reported by Bliss GVS Pharma Limited for Third Quarter FY, 2020-21 |
| Current Quarter (October, 2020 - December, 2020) |
Previous Quarter (July, 2020 - September, 2020) |
Corresponding Quarter (October, 2019 - December, 2019) |
9 Months Ended (April, 2020 - December, 2020) |
Corresponding 9 Months Ended (April, 2019 - December, 2019) |
| 51.65 |
35.00 |
39.40 |
41.68 |
34.84 |
| Calculated Gross Margin(%) of Bliss GVS Pharma Limited for Third Quarter FY, 2020-21 |
| Current(December, 2020) VS Previous(September, 2020) |
Current(December, 2020) VS Corresponding(December, 2019) |
9 months Ended(April, 2020 - December, 2020) VS Corresponding 9 months Ended(April, 2019 - December, 2019) |
| Change |
Change % |
Change |
Change % |
Change |
Change % |
| 16.65 |
47.57%(GM Increase) |
12.26 |
31.11%(GM Increase) |
6.84 |
19.64%(GM Increase) |
Gross Margin(%)/ GM: The company's financial report indicates, the company's GM increased by 47.57% in QoQ(Quarter on Quarter) / current quarter(October, 2020 - December, 2020) for 16.65% GM increase, as the company reported 51.65% GM; in compare to previous quarter(July, 2020 - September, 2020) when the company reported 35.00% GM.
The result also indicates, the company's GM increased by 31.11% in YoY(Year over Year) / in current quarter(October, 2020 - December, 2020) for 12.26% GM increase; in compare to corresponding quarter(October, 2019 - December, 2019) when the company reported 39.40% GM.
The company also reported that its GM increased by 19.64% in 9 months end(April, 2020 - December, 2020) for 6.84% GM increase, since the company reported 41.68% GM; in compare to corresponding 9 months end(April, 2019 - December. 2019) when the company reported 34.84% GM.
| EBITDA Reported by Bliss GVS Pharma Limited for Third Quarter FY, 2020-21 |
| Current Quarter (October, 2020 - December, 2020) |
Previous Quarter (July, 2020 - September, 2020) |
Corresponding Quarter (October, 2019 - December, 2019) |
9 Months Ended (April, 2020 - December, 2020) |
Corresponding 9 Months Ended (April, 2019 - December, 2019) |
| 42.39 |
34.75 |
38.46 |
103.66 |
127.90 |
| Calculated EBITDA of Bliss GVS Pharma Limited for Third Quarter FY, 2020-21 |
| Current(December, 2020) VS Previous(September, 2020) |
Current(December, 2020) VS Corresponding(December, 2019) |
9 months Ended(April, 2020 - December, 2020) VS Corresponding 9 months Ended(April, 2019 - December, 2019) |
| Change |
Change % |
Change |
Change % |
Change |
Change % |
| 7.64 |
21.99%(EBITDA Increase) |
3.93 |
10.22%(EBITDA Increase) |
24.24 |
18.95%(EBITDA Decrease) |
EBITDA/ Earnings before interest, tax, depreciation and amortization: The company's financial report shows that the company's EBITDA increased by 21.99% in QoQ(Quarter on Quarter) / current quarter(October, 2020 - December, 2020) for EBITDA increase of Rs.7.64 crores, as the company posted EBITDA of Rs.42.39 crores; in compare to previous quarter(July, 2020 - September, 2020) when the company reported EBITDA of Rs.34.75 crores.
The result also shows that the company's EBITDA increased by 10.22% in YoY(Year over Year) / in current quarter(October, 2020 - December, 2020) for EBITDA increase of Rs.3.93 crores; in compare to corresponding quarter(October, 2019 - December, 2019) when the company posted EBITDA of Rs.38.46 crores.
The company also reported that its EBITDA decreased by 18.95% in 9 months end(April, 2020 - December, 2020) for EBITDA decrease of Rs.24.24 crores, since the company reported EBITDA of Rs.103.66 crores; in compare to corresponding 9 months end(April, 2019 - December. 2019) when the company posted EBITDA of Rs.127.90 crores.
| Profit and Loss Reported by Bliss GVS Pharma Limited for Third Quarter FY, 2020-21 |
| Current Quarter (October, 2020 - December, 2020) |
Previous Quarter (July, 2020 - September, 2020) |
Corresponding Quarter (October, 2019 - December, 2019) |
9 Months Ended (April, 2020 - December, 2020) |
Corresponding 9 Months Ended (April, 2019 - December, 2019) |
| 27.56(Profit ) |
21.61(Profit ) |
25.45(Profit ) |
65.82(Profit ) |
89.68(Profit ) |
| Calculated Profit and Loss of Bliss GVS Pharma Limited for Third Quarter FY, 2020-21 |
| Current(December, 2020) VS Previous(September, 2020) |
Current(December, 2020) VS Corresponding(December, 2019) |
9 months Ended(April, 2020 - December, 2020) VS Corresponding 9 months Ended(April, 2019 - December, 2019) |
| Change |
Change % |
Change |
Change % |
Change |
Change % |
| 5.95 |
27.53%(Profit Increase) |
2.11 |
8.29%(Profit Increase) |
23.86 |
26.61%(Profit Decrease) |
Profit and Loss / PAT(Profit after Tax): The company's financial report shows that the company's profit increased by 27.53% in QoQ(Quarter on Quarter) / current quarter(October, 2020 - December, 2020) for profit increase of Rs.5.95 crores, as the company posted profit of Rs.27.56 crores; in compare to previous quarter(July, 2020 - September, 2020) when the company reported profit of Rs.21.61 crores.
The result also shows that the company's profit increased by 8.29% in YoY(Year over Year) / in current quarter(October, 2020 - December, 2020) for profit increase of Rs.2.11 crores; in compare to corresponding quarter(October, 2019 - December, 2019) when the company posted profit of Rs.25.45 crores.
The company also reported that its profit decreased by 26.61% in 9 months end(April, 2020 - December, 2020) for profit decrease of Rs.23.86 crores, since the company reported profit of Rs.65.82 crores; in compare to corresponding 9 months end(April, 2019 - December. 2019) when the company posted profit of Rs.89.68 crores.
| EPS Reported by Bliss GVS Pharma Limited for Third Quarter FY, 2020-21 |
| Current Quarter (October, 2020 - December, 2020) |
Previous Quarter (July, 2020 - September, 2020) |
Corresponding Quarter (October, 2019 - December, 2019) |
9 Months Ended (April, 2020 - December, 2020) |
Corresponding 9 Months Ended (April, 2019 - December, 2019) |
| 2.48 |
1.99 |
2.30 |
6.03 |
8.58 |
| Calculated EPS of Bliss GVS Pharma Limited for Third Quarter FY, 2020-21 |
| Current(December, 2020) VS Previous(September, 2020) |
Current(December, 2020) VS Corresponding(December, 2019) |
9 months Ended(April, 2020 - December, 2020) VS Corresponding 9 months Ended(April, 2019 - December, 2019) |
| Change |
Change % |
Change |
Change % |
Change |
Change % |
| 0.49 |
24.62%(EPS Increase) |
0.18 |
7.83%(EPS Increase) |
2.55 |
29.72%(EPS Decrease) |
EPS /Earning per Share: The company's financial report shows that the company's EPS increased by 24.62% in QoQ(Quarter on Quarter) / current quarter(October, 2020 - December, 2020) for EPS increase of Rs.0.49, as the company posted EPS of Rs.2.48; in compare to previous quarter(July, 2020 - September, 2020) when the company reported EPS of Rs.1.99.
The result also shows that the company's EPS increased by 7.83% in YoY(Year over Year) / in current quarter(October, 2020 - December, 2020) for EPS increase of Rs.0.18; in compare to corresponding quarter(October, 2019 - December, 2019) when the company posted EPS of Rs.2.30.
The company also reported that its EPS decreased by 29.72% in 9 months end(April, 2020 - December, 2020) for EPS decrease of Rs.2.55, since the company reported EPS of Rs.6.03; in compare to corresponding 9 months end(April, 2019 - December. 2019) when the company posted EPS of Rs.8.58.
***All amounts are given in Crore Indian Rupees(INR) except EPS (Earnings per share) which are in Indian Rupees(INR) only.***
Gross Margin=Total Revenue from Operations -(Cost of Materials Consumed + Purchases of stock-in-trade - Changes in inventories of finished goods, work-in-progress and stock-in-trade).
Gross Margin%=(Gross Margin / Total Revenue from Operations)*100.
EBITDA=Commission/Interest + Depreciation and Amortization + Tax + Profit/Loss (PAT).
1 Lac = 100,000.
1 Million = 10 Lacs.
1 Crore = 10 Millions.
1 Crore = 100 Lacs.
1 Billion = 1000 Millions.
1 Billion = 100 Crores.
Add new comment